{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T18:21:15Z","timestamp":1776709275168,"version":"3.51.2"},"reference-count":36,"publisher":"Begell House","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Crit Rev Eukaryot Gene Expr"],"published-print":{"date-parts":[[2025]]},"abstract":"<p>&lt;b&gt;Background: &lt;\/b&gt;Spinal tuberculosis (ST) poses a significant health risk as a severe infectious disease. MicroRNAs (miRNAs), key regulatory molecules, are implicated in the initiation and progression of ST. However, a comprehensive understanding of miRNA networks and their regulatory roles in ST remains insufficient.\n\n&lt;b&gt;Methods:&lt;\/b&gt; Differential expression analysis of miRNAs between ST and healthy control (HC) samples was conducted using the GSE225679 dataset from the GEO database. Functional enrichment and transcription factor analyses were performed with FunRich software. To evaluate the diagnostic potential of the identified miRNAs, four machine learning models-support vector machine (SVM), random forest (RF), generalized linear model (GLM), and extreme gradient boosting (XGB)- were employed. A nomogram model was developed based on the optimal SVM results. In addition, &lt;i&gt;in vitro&lt;\/i&gt; experiments examined the impact of miR-1229-3p inhibition on cell proliferation, osteoclast formation (via TRAP staining), and the expression of inflammatory cytokines (IL-6, TNF-&amp;alpha;, IL-1&amp;beta;, IL-17) using CCK-8, RT-qPCR, and Western blot techniques.\n\n&lt;b&gt;Results:&lt;\/b&gt; A total of 257 differentially expressed miRNAs were identified, with 143 upregulated and 114 downregulated. Among the four models, SVM demonstrated the highest diagnostic accuracy, identifying five key miRNAs associated with ST (hsa-miR-4305, hsa-miR-3686, hcmv-miR-UL148D, ebv-miR-BHRF1-1, and hsa-miR-1229-3p). A miRNA-mRNA regulatory network was constructed, comprising 116 interaction pairs, involving three upregulated miRNAs and 57 downregulated target mRNAs. Additionally, a network of target genes and molecular drugs was established, which included 11 target genes and 224 candidate drugs. &lt;i&gt;In vitro &lt;\/i&gt;data showed that inhibiting miR-1229-3p significantly decreased cell proliferation, osteoclast formation, and the expression of IL-6, TNF-&amp;alpha;, IL-1&amp;beta;, and IL-17 in tuberculin-stimulated cells.\n\n&lt;b&gt;Conclusion: &lt;\/b&gt;This study offers new insights into the miRNA-mediated regulatory mechanisms in ST and highlights potential miRNA biomarkers for disease characterization.<\/p>","DOI":"10.1615\/critreveukaryotgeneexpr.2025059856","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T14:07:55Z","timestamp":1756303675000},"page":"65-79","source":"Crossref","is-referenced-by-count":1,"title":["Screening of miRNAs Characterizing Spinal Tuberculosis and Construction of Its Regulatory Network"],"prefix":"10.1615","volume":"35","author":[{"given":"Wenxin","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shichao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"613","reference":[{"key":"2","doi-asserted-by":"crossref","unstructured":"Garg RK, Somvanshi DS. Spinal tuberculosis: A review. J Spinal Cord Med. 2011;34(5):440-54.","DOI":"10.1179\/2045772311Y.0000000023"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Ferrer MF, Torres LG, Ram\u00ef\u00bf\u00bdrez OA, Zarzuelo MR, del Prado Gonz\u00e1lez N. Tuberculosis of the spine. A systematic review of case series. Int Orthop. 2012;36(2):221-31.","DOI":"10.1007\/s00264-011-1414-4"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Wang B, Gao W, Hao D. Current study of the detection and treatment targets of spinal tuberculosis. Curr Drug Targets. 2020;21(4):320-7.","DOI":"10.2174\/1389450120666191002151637"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Chipeio ML, Sayah A, Hunter CJ. Spinal tuberculosis. Am J Trop Med Hyg. 2021;104(5):1605-6.","DOI":"10.4269\/ajtmh.20-1529"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Xu Z, Wang X, Shen X, Luo C, Wu P, Zeng H. One-stage lumbopelvic fixation in the treatment of lumbosacral junction tuberculosis. Eur Spine J. 2015;24(8):1800-5.","DOI":"10.1007\/s00586-015-3863-8"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Wang B, Kong L, Zhu Z, Gao W, Guo H, Wang X, Li H, Zhao Q, Zhang H, Hao D. Recurrent complex spinal tuberculosis accompanied by sinus tract formation: Causes of recurrence and clinical treatments. Sci Rep. 2018;8(1):6933.","DOI":"10.1038\/s41598-018-25142-z"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Zhu Z, Hao D, Wang B, Gao W, Yang R, Guo H, Wang Y, Kong L. Selection of surgical treatment approaches for cervicothoracic spinal tuberculosis: A 10-year case review. PLoS One. 2018;13(2):e0192581.","DOI":"10.1371\/journal.pone.0192581"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Dorman S. Advances in the diagnosis of tuberculosis: Current status and future prospects. Int J Tuberc Lung Dis. 2015;19(5):504-16.","DOI":"10.5588\/ijtld.15.0048"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Merino P, Candel FJ, Gestoso I, Baos E, Picazo J. Microbiological diagnosis of spinal tuberculosis. Int Orthop. 2012;36(2):233-8.","DOI":"10.1007\/s00264-011-1461-x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Garg RK, Somvanshi DS. Spinal tuberculosis: A review. J Spinal Cord Med. 2011;34(5):440-54.","DOI":"10.1179\/2045772311Y.0000000023"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Khanna K, Sabharwal S. Spinal tuberculosis: A comprehensive review for the modern spine surgeon. Spine J. 2019;19(11):1858-70.","DOI":"10.1016\/j.spinee.2019.05.002"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Cui X, Li Y, Bao J, Wang K, Wu X. Downregulation of miR-760 causes human intervertebral disc degeneration by targeting the MyD88\/Nuclear Factor-Kappa B signaling pathway. Front Bioeng Biotechnol. 2022;10:813070.","DOI":"10.3389\/fbioe.2022.813070"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Senese R, Petito G, Silvestri E, Ventriglia M, Mosca N, Potenza N, Russo A, Manfrevola F, Cobellis G, Chioccarelli T, Porreca V, Mele VG, Chianese R, de Lange P, Ricci G, Cioffi F, Lanni A Effect of CB1 receptor deficiency on mitochondrial quality control pathways in gastrocnemius muscle. Biology. 2024;13(2).","DOI":"10.3390\/biology13020116"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Cammaerts S, Strazisar M, De Rijk P, Del Favero J. Genetic variants in microRNA genes: Impact on microRNA expression, function, and disease. Front Genet. 2015;6:186.","DOI":"10.3389\/fgene.2015.00186"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Nawata CM, Pannabecker TL. Mammalian urine concentration: A review of renal medullary architecture and membrane transporters. J Comp Physiol B. 2018;188(6): 899-918.","DOI":"10.1007\/s00360-018-1164-3"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Michell DL, Vickers KC. Lipoprotein carriers of microRNAs. Biochim Biophys Acta. 2016;1861(12 Pt B):2069-74.","DOI":"10.1016\/j.bbalip.2016.01.011"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Yang C, Shi Z, Hu J, Wei R, Yue G, Zhou D. miRNA-155 expression and role in pathogenesis in spinal tuberculosis-induced intervertebral disc destruction. Exp Ther Med. 2019;17(4):3239-46.","DOI":"10.3892\/etm.2019.7313"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Sun Z, Pang X, Wang X, Zeng H. Differential expression analysis of miRNAs in macrophage-derived exosomes in the tuberculosis-infected bone microenvironment. Front Microbiol. 2023;14:1236012.","DOI":"10.3389\/fmicb.2023.1236012"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Liang Q, Jin W, Huang Z, Yin H, Liu S, Liu L, Liu L, Song X, Wang Z, Fei J. A plasma 3-marker microRNA biosignature distinguishes spinal tuberculosis from other spinal destructive diseases and pulmonary tuberculosis. Front Cell Infect Microbiol. 2023;13:1125946.","DOI":"10.3389\/fcimb.2023.1125946"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Feng L, Zhu M, Zhang X, Niu N, Shi Z. METTL14 mediates the m6A methylation of miR-29a-3p, thereby activating the MAP2K6 signaling pathway and exacerbating the inflammatory response associated with spinal tuberculosis. J Orthop Surg Res. 2025;20(1):625.","DOI":"10.1186\/s13018-025-06037-y"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Adhikary S, Leo S, Banerjee A, Pathak S, Narasimhan M, Rathinam S. Evaluating the expression level of serum Interleukin-2, lipoarabinomannan and circulating MicroRNA-29a as diagnostic biomarkers for pulmonary and extra-pulmonary tuberculosis: A pilot study. Ann Med. 2025;57(1):2527949.","DOI":"10.1080\/07853890.2025.2527949"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Boumait Y, Ettetuani B, Chrairi M, Lamzouri A, Chahboune R. Identification of gene expression biomarkers predictive of latent tuberculosis infection using machine learning approaches. Genes. 2025;16(6).","DOI":"10.3390\/genes16060715"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Li F, Tan H, Zhang X, Zhao X, Li X, Chen G. LncRNA HCG18 regulates the progression of spinal tuberculosis by modulating the hsa-miR-146a-5p\/TGF-B1\/SMADs pathway. J Orthop Surg Res. 2025;20(1):484.","DOI":"10.1186\/s13018-025-05810-3"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Sukdeo Y, Shozi NP, Ndimande N, Mbara KC, Owira PMO. A review of the human microRNA and the Mycobacterium tuberculosis epigenetic effects on the emergence drug resistance. Life Sci. 2025;374:123637.","DOI":"10.1016\/j.lfs.2025.123637"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Kurtz SL, Baker RE, Boehm FJ, Lehman CC, Mittereder LR, Khan H, Rossi AP, Gatti DM, Beamer G, Sassetti CM, Elkins KL. Multiple genetic loci influence vaccine-induced protection against Mycobacterium tuberculosis in genetically diverse mice. PLoS Pathog. 2024;20(3):e1012069.","DOI":"10.1371\/journal.ppat.1012069"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Rubanyi GM, Botelho LH. Endothelins. FASEB J. 1991;5(12):2713-20.","DOI":"10.1096\/fasebj.5.12.1916094"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Fu B, Xiong Y, Sha Z, Xue W, Xu B, Tan S, Guo D, Lin F, Wang L, Ji J, Luo Y. SEPTIN2 suppresses an IFN-gamma-independent, proinflammatory macrophage activation pathway. Nat Commun. 2023 Nov 17;14(1):7441.","DOI":"10.1038\/s41467-023-43283-2"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Ng CT, Fong LY, Abdullah MNH. Interferon-gamma (IFN-gamma): Reviewing its mechanisms and signaling pathways on the regulation of endothelial barrier function. Cytokine. 2023;166:156208.","DOI":"10.1016\/j.cyto.2023.156208"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Peach CJ, Mignone VW, Arruda MA, Alcobia DC, Hill SJ, Kilpatrick LE, Woolard J. Molecular pharmacology of VEGF-A isoforms: Binding and signalling at VEGFR2. Int J Mol Sci. 2018;19(4):1264.","DOI":"10.3390\/ijms19041264"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Gao L, Yu W, Song P, Li Q. Non-histone methylation of SET7\/9 and its biological functions. Recent Pat Anticancer Drug Discov. 2022;17(3):231-43.","DOI":"10.2174\/1574892816666211202160041"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Singh R, Magu NK, Rohilla RK. Clinicoradiologic profile of involvement and healing in tuberculosis of the spine. Ann Med Health Sci Res. 2016;6(5):311-27.","DOI":"10.4103\/amhsr.amhsr_188_15"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Li K, Liu B, Zhang Q. Recurrent spinal tuberculosis with HIV infection after surgery: A rare case of recurrence and drug resistance. Infect Drug Resist. 2023;16:7827-33.","DOI":"10.2147\/IDR.S438184"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Aurangabadkar GM, Choudhary SS, Khan SM, Jadhav US, Wagh PB, Ali SN. Post-tubercular unilateral lung destruction: A complicated case. Cureus. 2023;15(6): e40035.","DOI":"10.7759\/cureus.40035"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Zhou M, Peng Y, Liu K, Zhou L, Wang F, Chen X, Chen B, Hu C. Direct medical expenses and influencing factors of MDR\/RR-TB in Eastern China: Based on data from multi-hospital information systems. Risk Manag Healthc Policy. 2023:1955-65.","DOI":"10.2147\/RMHP.S420082"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Panford V, Kumah E, Kokuro C, Adoma PO, Baidoo MA, Fusheini A, Ankomah SE, Agyei SK, Agyei-Baffour P. Treatment outcomes and associated factors among patients with multidrug-resistant tuberculosis in Ashanti Region, Ghana: A retrospective, cross-sectional study. BMJ Open. 2022;12(7):e062857.","DOI":"10.1136\/bmjopen-2022-062857"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Mesfin EA, Beyene D, Tesfaye A, Admasu A, Addise D, Amare M, Dagne B, Yaregal Z, Tesfaye E, Tessema B. Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia. PLoS One. 2018;13(6):e0197737.","DOI":"10.1371\/journal.pone.0197737"}],"container-title":["Critical Reviews in Eukaryotic Gene Expression"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dl.begellhouse.com\/download\/article\/561cd46736825e80\/CRE-59856.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T05:26:24Z","timestamp":1761283584000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dl.begellhouse.com\/journals\/6dbf508d3b17c437,6b924d6f5521c33e,561cd46736825e80.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1615\/critreveukaryotgeneexpr.2025059856","relation":{},"ISSN":["1045-4403"],"issn-type":[{"value":"1045-4403","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}